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The growing interest in using Ayurvedic medicine as a gentler, safer option to using modern medicine
drugs with attendant side effects continues to be thwarted because claims about effectiveness and safety
are not backed with evidence and clinical data. The focus of Ayurveda practice and research should be on
building bridges to this knowledge for public beneﬁt. The consumer is being denied basic knowledge,
access to product information as well as the beneﬁt of a common prescription written by a single treating
physician because of three factors e Ayurvedic OTC medicine is generally sold with names and labels
which cannot be understood by the consumer despite being easily available without prescription; the
treating modern medicine doctor is being prevented from writing the name of a herbal product even
when he is individually convinced about its usefulness (in given circumstances) and the absence of
biomedical research using objective parameters proving the effectiveness of the drugs. Contemporary
Ayurveda needs to be packaged to reach the modern consumer in a way that he gets the beneﬁt of access
to treatment options that assist healing within the ambit of the law. These obstacles have to be removed.
Patient- based effectiveness studies using retrospective case material as well as research using inter-
disciplinary approaches are needed for public beneﬁt. This has to be facilitated.
© 2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction old, has been in active use for centuries, is recognised under theThe year 2016 started on a new note for the world of AYUSH e
the acronym for Indian systems of medicine including Ayurveda,
Yoga, Unani, Siddha and Homoeopathy. This was the ﬁrst time that
at a public platform, while addressing an international conference
on the frontiers of yoga, the Prime Minister spoke words yet un-
stated by his predecessors. The challenge he posed had seldom
been confronted by the traditional medicine community-a large
and inﬂuential group with wide public interface. He said,
“We must also apply the techniques and methods of modern
science, to test and validate results, assure quality and explain
beneﬁts.” [1].
For a gathering of traditional medicine experts and practitioners
it was to say the least unexpected, coming as it did from a strong
proponent of Indian traditions. For years champions of the system
have avoided undertaking rigourous clinical research with argu-
ments ranging from the fact that Ayurveda is thousands of yearselhi 110057, India.
ary University, Bangalore.
alore and World Ayurveda Foundat
es/by-nc-nd/4.0/).Drugs and Cosmetics Act, uses formulations that are well-
documented in the Ayurvedic formularies and pharmacopoeias
and the practitioners possess a medical degree and are registered
under the Indian Medicine Council Act. Being a parallel setup to
modern medicine, the approach by and large has been that there is
no need for making comparisons e and least of all with modern
medicine.
2. The dilemma facing Ayurveda
What the Prime Minister stated was extraordinary because he
indirectly acknowledged that the benchmark for bio-medical
research set by modern medicine (in the absence of any other
standard) would need to be used to prove the claims about Ayur-
veda. India is in a piquant situation because every registered
practitioner of the system can use the therapeutics and drugs to
treat every kind of medical condition. The drugs are freely available
across the counter in special shops and sometimes even stocked by
regular chemists selling allopathic drugs [2,3]. Thousands of Ay-
urvedic formulations both classical as well as proprietary are sold in
every state and their licencing and manufacture are backed by a
legal process set out in a dedicated chapter of the Drugs and Cos-
metics Act 1940. Ayurveda formulations run into thousands of
items. Most formulations contain several plant-based, mineral andion. Publishing Services by Elsevier B.V. This is an open access article under the CC
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jellies, tablets, syrups or oils requires knowledge of the ingredients
as well as of the processing. Only a few Ayurvedic drugs are sold as
capsules or tablets. Although some items are easily identiﬁable,
most of them have Sanskrit names which are unfamiliar to lay
people. Although the drugs are marketed throughout India, there is
distinctiveness about the drugs manufactured in the southern and
western states of India where the use of Ayurveda is also more
widespread and acceptable.
However diagnosis and treatment including drug prescription
do not follow standard operating procedures or drug regimens both
of which are integral features of allopathic treatment. In Ayurveda,
each individual is believed to have a special and unique constitu-
tion and the choice of therapeutic treatment is individualistic and
holistic [4]. Diagnosis is done in a patient speciﬁc manner and
treatment is custom-made. While some physicians may be guided
by the outcome of modern diagnostics and pathological ﬁndings,
others may depend only on a clinical examination.
Patients seldom ask questions about ingredients or the basis of
knowing the safety and efﬁcacy of the drugs. If however such a
question is asked, the standard reply is that the recipe is contained
in the classical texts and that the formulations have been in use for
hundreds of years. Either the clientele does not ask any further
questions or remains dissatisﬁed, but silent. As a result the
numbers of those who avail of Ayurvedic treatment are limited to
those who have used it as a family tradition and have intrinsic faith
in the system. Newcomers are curious but remain cautious despite
a growing interest in ﬁnding natural ways of healing and an
avoidance of strong, chemical medication.
In the absence of published clinical research which has inves-
tigated the safety and effectiveness of the Ayurvedic approaches in
treating human beings, wider public remains unconvinced and
unsure. Whether articulated or not, there is scepticism about the
mode of action of Ayurvedic therapeutics and drugs. In Ayurveda
more than medication the emphasis is on maintaining a healthy
lifestyle as a precursor to treating a medical condition. This be-
comes daunting for patients who have been accustomed to fast
diagnosis followed by a pill-popping regimen which generally
provides quick relief.
3. Ayurvedic way of life-an essential component of patient
management
The Ayurvedic approach is entirely different, is time-taking
and often cumbersome. There is heavy dependence on ablu-
tions, purgation, the use of medicated oils and the consumption
of sometimes rather unpalatable decoctions and medication. Two
precepts which are integral to Ayurveda are Dinacharya and Rit-
ucharya which demand adherence to a strict daily regimen of
eating, sleeping, taking a daily bath after evacuating the bowels
ﬁrst thing in the morningeextended even to the cultivation of a
happy disposition [5]. There is a great emphasis on eating freshly
cooked food, on the intake of green vegetables and on the
observance of regular meal timings and intake of water. Taste is
also very important and salty, sweet, spicy and bitter prepara-
tions are advised as a part of an Ayurvedic diet. Most Indian
families even if they do not claim to be practising Ayurveda,
understand the importance of eating what nature produces in
abundance during a particular season. Vegetables like spinach
and cabbage are discouraged during the rainy months because of
the pathogens that exist in muddy water. The fact that cruciferous
vegetables like cabbage and cauliﬂower produce gas (vata) is
known to most Indian housewives and is routinely countered
with the addition of anti-ﬂatulence agents like ginger and cumin
while cooking.4. Traditional knowledge digital library
The properties of every single ingredient used in Indian
cooking e turmeric, cumin, coriander, cayenne, fenugreek and
spices like pepper, cinnamon, clove, cardamom and nutmeg have
been described in hundreds of stanzas in the ancient Ayurvedic
texts and classical literature written some 1500 years ago. And
the fact that this is Ayurvedic knowledge has been acknowledged,
certiﬁed and legitimised by the World Intellectual Property
Organisation is indicative of its value. When patents on turmeric,
jamun and karela (bitter gourd) were ﬁled the Ministry in-charge
of AYUSH established a Traditional Knowledge Digital Library
(TKDL) to scan references to every single ingredient and formu-
lation listed in selected classical texts. These were then translated
into six UN languages and presented in a patent compatible
format to the patent ofﬁces in different countries. The project
required engagement of scores of Ayurvedic experts, Indian pat-
ent examiners and computer programmers but the outcome was
that TKDL has been able to prevent the grant of some 300 patents
simply because the domain knowledge could be shown as having
existed in the ancient texts of Ayurveda for centuries. As a result
knowledge about the healing properties of innumerable plants
used in Ayurveda could no longer be claimed as an invention or a
discovery [6].
5. The challenges of harnessing ayurvedic knowledge for
research
Having thus established the primacy of Ayurveda's traditional
knowledge before the world, a bigger challenge remains unmet:
how can this knowledge be used for public beneﬁt? Without
research and publication in quality journals the process of valida-
tion will not be complete. Even if the properties of the medicinal
plants can be established through research, it can only translate
into larger public beneﬁt if biomedical research proves that the
treatment including the medication possesses the capacity to pre-
vent ill-health, promote good health or cure disease. That requires
research protocols that exclude bias, access to patients and tabu-
lation of outcomes. That in fact has been the Achilles heel of
Ayurveda.
Pharmacological research on the healing properties of plants
has been undertaken for long. Things become complex when it
comes to clinical research on human beings. And that takes us
to the root of the problem. Clinical research conducted accord-
ing to protocols set out for modern biomedical research requires
that patients be treated using randomised controlled trials.
These necessarily require three things at the minimum: sufﬁ-
cient number of patients, an inclusion and exclusion criteria for
the selection of subjects, standardised medicine and sometimes
even placebos. Ayurvedic medicine is by its very nature indi-
vidualised. Ayurvedic herbs may have been collected from the
wild, or from cultivated sources; they may have been collected
during different seasons which impacts the properties of the
plants including the effectiveness of the raw drugs. Although
the term “standardisation” as applicable to modern pharma-
ceutical drugs does not apply to Ayurveda drugs, batch to batch
quality testing and certiﬁcation about compliance with permis-
sible levels for contaminants, microbial and heavy metals cannot
be ignored. But this needs investments in quality control which
is not forthcoming. The Ayurveda industry has not given priority
to such aspects, forever seeking subsidies for something as basic
as batch to batch testing. The tests prescribed in the Ayurvedic
pharmacopeias' are inadequate but even so, enforcement has
been weak. In comparison the allopathic pharmaceutical in-
dustry has been investing in GMP and quality control and has
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the same level of standardisation is not required, basic unifor-
mity and adherence to pharmacopeia standards would have to
be certiﬁed [7].
6. Ethical requirements relating to non-toxicity of Ayurvedic
ingredients
When it comes to administering Ayurvedic medicine as a part
of a research study, ethical requirements would necessitate that
the patient is told about the ingredients. While it may be possible
to use instruments like the Inductively Coupled Plasma Analyser
or the more commonly used Atomic Absorption Spectrophotom-
eter to detect impurities and rule out the presence of substances
that exceed permissible levels, this cannot be done across the
board without heavy investment in laboratories and equipment.
Such investment may exceed even the budget available for
research. Meanwhile the use of mercury, lead, gold, pearls and
coral which are integral to some Ayurvedic formulations (albeit
used in some 5% of the formulations only) may deter many a
patient from opting for Ayurvedic treatment as part of a research
project. The mere statement that the ingredients have been pu-
riﬁed according to a complex Ayurvedic process and converted
into “nanoparticles”will not satisfy the tenets of science or the
anxiety of the patient.
The fair name of Ayurveda has regularly come in for interna-
tional criticism on account of the issue of toxicity. This fear is de-
terring many countries from according ofﬁcial recognition to
Ayurveda. An increasing number of negative reports have been
published over the years (at least 45 are found on PubMed as of
now). The usual reaction is either to say that western lobbies are
deliberately portraying Ayurvedic medication in poor light or to
blame the manufacturer for non-adherence to the rigorous
methods of puriﬁcation. Clinical research using the approaches of
modern medicine cannot be conducted against a backdrop of
distrust.
The issue must be confronted by pre-empting criticism instead
of deﬂecting adverse reports. Needed is a mandatory requirement
for toxicity screening (liver and renal function tests, blood pa-
rameters etc.) in patients who are on Ayurveda drugs which
contain metallic ingredients. Public cooperation must be sought
in completing the prescribed forms which alone can facilitate
regular pharmaco-vigilance to report adverse drug reactions. In
the long run this alone can provide safety data on Ayurvedic
formulations.
7. Where is the evidence? where is the data?
Apart from toxicity, there is the question of efﬁcacy and effec-
tiveness. With all the constraints, a section among thinking,
knowing and educated people has been voluntarily opting for Ay-
urvedic treatment for certain conditions, particularly in the states
of Kerala and Maharashtra. When cases of infertility are success-
fully tackled by Ayurvedic physicians, where is the evidence that
such cases earlier relegated to the status of failures by allopathic
hospitals were the result of Ayurvedic treatment? Where is the
evidence that people with chronic back or joint pain who have
recovered substantially have done so because of Ayurvedic pan-
chakarma treatment? Where is the evidence that the quality of life
of terminally ill patients or those on chemotherapy actually
improved with the intake of Ayurvedic medicine? What is the way
of converting some extraordinary outcomes which are today in the
realm of subjective evidence only, into dependable research ﬁnd-
ings backed by credible data? While whatever treatment is un-
dertaken is completely covered by Indian laws, where is theevidence that it has had any positive effect and no negative effects
on the patient?
8. Clinical research and public beneﬁt
Having posed all these problems is there a solution? First, in no
case is this article an argument to support clinical research to the
exclusion of other kinds of research. The fundamentals of Ayurveda,
the basic precepts like tridosha, panchamahabootas, ojas, chakras
and dhatus must be undertaken because that is the foundation on
which Ayurveda rests. When the mode of action and the basis for
diagnosis is questioned it is only through such research that an-
swers can be given. It is equally important that literary research on
the ancient manuscripts, on drug standardisation, on the effec-
tiveness of reverse pharmacology as an alternative way of
explaining the Ayurvedic phenomena are undertaken and sup-
ported. But while these outcomes may beneﬁt Ayurveda as a
medical system, it will not give direct quantiﬁable medical options
for patient beneﬁt in the foreseeable future. In the eyes of a curious
public looking for new, better and safer options and preferably
natural options, the need of the hour is to conduct clinical research
in the most acceptable way, recognising that RCTs are virtually
unattainable. It may be noted that there have been suggestions
from experts regarding the need for ‘whole system trials’ which
should adhere to the principles of Ayurveda [8,9].
Alternatives are feasible but they must be given a chance.
Against the backdrop of so many obstacles standing in the way of
clinical research as prescribed by modern medicine, perhaps clin-
ical research on Ayurvedic treatment should be channelised
differently.
9. Clinical research without RCTs
First, there is a need to seek volunteers from among patients
that throng the OPD's of large hospitals dealing with speciality
medical conditions e arthritis, early diabetes, hypertension, irri-
table bowel syndrome and skin diseases, physical disability related
to computer overuse and suchlike would ﬁnd many takers. Only
the Ministry of Health can authorise notices to be displayed in
allopathic clinics seeking volunteers who seek Ayurvedic treat-
ment at government cost. Ideally such volunteers should be
informed about the treatment regimen but the physician should
be allowed to prescribe the treatment according to his judgement,
on a case to case basis. The progress can be assessed by a multi-
disciplinary group which has not been associated with the treat-
ment and their ﬁndings could be limited to examining the
pathological parameters before, during and after treatment and
observing improvements or the lack thereof using such diagnostic
tools and pathological investigations. The patient's own account of
improvement or the absence thereof should also be recorded
along with observation on the patient's outward capacity to
perform functions which were impeded earlier. In this way at least
some broad idea about the beneﬁts of Ayurvedic treatment would
be available.
10. Retrospective studies to establish efﬁcacy and
effectiveness
Second, there is huge scope for undertaking retrospective
studies. There are perhaps thousands if not tens of thousands of
patient case records lying in several Ayurveda centres, especially
in Ayurveda colleges of South India, Maharashtra (Kottaikal,
Udupi, Pune and Thiruvananthapuram) to name just a few. Un-
complicated user friendly software could be developed which
would enable the data to be analysed in a simple, efﬁcient way. A
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sheets of patients who had been under treatment for around 15
health conditions which are commonly treated at leading Ayur-
vedic centres. The results could be analysed and published
covering the beneﬁcial effects of Ayurvedic interventions in say
1000 cases of stroke, paralysis after spinal injury, of improvement
in the quality of life (appetite, reduction of nausea, constipation,
diarrhoea, sleep disorders) in the case of patients undergoing
tuberculosis treatment or chemotherapy to name just two. Not
only will this encourage other hospitals which wish to get
involved in research in maintaining proper records but it will give
acceptable, publishable data on what Ayurveda can achieve
without starting clinical research de novo. Even the experts have
suggested that gathering evidence from Ayurveda practise needs
to be encouraged [10].
Although retrospective have inherent limitations but
discharge summaries are considered veriﬁable and authentic
documents from the point of view of research [11]. Perhaps
retrospective studies might reveal more information than what
clinical efﬁcacy studies might bring out as many of them would
provide data over several years. This approach would enable
valuable data which is available being used and would save
precious time on creating new protocols and ﬁnding suitable
clinical material.
11. Bridging the Ayurveda e Allopathy divide
Third, since the biggest proponents of the efﬁcacy of Ayurvedic
drugs are often the modern medicine practitioners themselves,
they need to be approached in an upfront manner. This is an area
which today is fraught with confusion and there is hesitation in
addressing it at a policy level. Some Ayurvedic drug manufacturers
have held extensive clinical trials using Ayurvedic single herbs and
formulations which are on the whole is simpler than the classical
formulations. As a part of what is called “ethical marketing”
modern medicine physicians are regularly being made aware
about the constitution of the Ayurvedic drugs, their therapeutic
action, indications for use, limitations and their role in clinical
practice.
Ayurvedic products are accepted by modern medicine physi-
cians if they are approached on similar lines as is done for intro-
ducing modern pharmaceutical drugs. If the data shows that the
research studies were undertaken with a proper design and the
outcomes have been published in good journals, modern medicine
physicians are prepared to listen because every professional doctor
has a desire to heal his patient. It is for that reason that wherever
the ethical marketing route has been adopted there have been
questions on the dosage schedule and advise on combining the
adjuvant use of Ayurvedic medication with allopathic treatment.
Many physicians add Ayurvedic drugs to their prescription only to
help the healing process. However they are arraigned by allopathic
medical associations e even for prescribing something as simple
and harmless as garlic or ginger capsules, a liver tonic or a pain
massage balm. Coming down heavily on cross practice even the
simplest applications are railed against even as the inter-
disciplinary medical warfare continues. This intrinsically harms
the interests of patients more than the doctors and must be seen
that way.
“Cross practice” was a term used by the Supreme Court when a
homoeopathic doctor administered allopathic drugs which led to
the death of the patient. In that context the apex court had
restricted the practice of medicine to the branch in which the
practitioner had been trained. But the circumstances and the
context were entirely different and the way cross practice is being
interpreted now begs the question as to who is being helped andwho is being harmed by preventing the use of what would fall in
the realm of herbal supplements. Ayurvedic drugs do not require a
prescription for sale but even so in allopathic doctor is precluded
from suggesting adjuvant use alongside allopathic treatment.
12. Ayurveda as Adjuvant therapy
A survey conducted under the aegis of the Central Council for
Research in Ayurveda [3], an organisation set up by the union
government, one thousand patients attending the OPDs of ﬁve
selected hospitals were asked about their preference for Ayurvedic
treatment as adjuvant therapy. Their reasons included a need to
avoid allopathic drugs which had side effects, prevent or postpone
surgery, to improve the quality of life, to mitigate symptoms, to
reduce the dosage of strong allopathic medicine and to avoid in-
jections as a mode of drug administration. Ayurvedic doctors from
the Municipal Corporation of Delhi and the ESI dispensaries indi-
cated how they were using Ayurvedic drugs as adjuvant therapy
while the treatment for diabetes, tuberculosis and other diseases
was in progress [3].
Manufacturers of proprietary have reported that the use of their
Ayurvedic formulations is particularly high in therapeutic cate-
gories like liver diseases; as immunomodulatory drugs to prevent
recurrent infections; for the nonsurgical management of urinary
disorders including renal calculus; to regulate irregular menstrua-
tion; for chronic skin ailments and the nonsurgical management of
haemorrhoids.
Given this background, to prevent an allopathic physician from
writing the name of an Ayurvedic medication on a prescription
when any citizen can access the medicine on his own (assuming he
can even recall the name) without prescription and labelling it as
cross practice is tantamount to distorting the intention behind the
judgement to deny the consumer the beneﬁt of accessing simple
remedies available over-the-counter. Since the consumer market
has already determined the utility of Ayurveda and the law of the
land allows medical pluralism, there is a need for a legal clariﬁca-
tion on the prescription of routine over-the-counter drugs by
modern medicine physicians. Debarring them from writing the
name of a single herb is preventing consumers from accessing what
is easily available but cannot be bought for want of knowledge
about the nomenclatures of Ayurvedic and botanical products.
There is a need to spread awareness about the efﬁcacy of stan-
dard, non-scheduled Ayurvedic medication which is in any case
available over-the-counter just like vitamins, tonics, cough syrups
et cetera. Even if there is no overt encouragement, at least the
present scope for discouraging modern medicine doctors from
suggesting the use of Ayurvedic drugs as adjuvants and palliative
agents needs clariﬁcation. The government could even seek a re-
view before the Supreme Court in the interest of consumers.
Otherwise medical lobbies and the modern Pharma sector will
continue to chide medical practitioners who use simple Ayurvedic
medicine as palliatives, immune system boosters and health en-
hancers. This is a travesty of justice and the consumer is the one
who gets short-changed.
13. Conclusion
When all is said and done, the antiquity, the experience and the
goodness of Ayurveda must be harnessed for the public good far
beyond what has been achieved until now. There is every need to
take up clinical research projects which would satisfy the tenets of
biomedical research but can be packaged differently. Perhaps the
best way of doing this is by throwing open not just the windows of
the mind but also genuine openness to multidisciplinary collabo-
ration with disciplines which have a stake in disease prevention,
S. Chandra / Journal of Ayurveda and Integrative Medicine 7 (2016) 6e1010natural healing and consumer rights. Finding partners among so-
ciologists, anthropologists modern medicine physicians and
teaming up with pharmacologists, biochemists, pharmacists and
qualiﬁed Ayurvedic experts in India as well as foreign countries
would bring fresh ideas and new ways of steering collaborative
research.
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